Literature DB >> 19932919

Vasculitis.

Carol A Langford1.   

Abstract

Vasculitis is defined by the presence of blood vessel inflammation. It can be observed in a wide variety of settings, which can be broadly grouped as secondary vasculitides, which occur in association with an underlying disease or trigger, or primary vasculitides, in which vasculitis is occurring for as-yet unknown causes. The primary systemic vasculitides comprise a range of disease entities that are uniquely identified by their clinical, histopathologic, and therapeutic characteristics. Individual diseases predominantly affect blood vessels of a particular size, which influences their clinical manifestations and has been used in their classification. The vasculitides can also differ in their severity, extending from self-limited illnesses to those that can be life-threatening in the absence of prompt initiation of treatment. Immunosuppressive agents are used to treat many vasculitic diseases. Although such approaches can be effective, the patient's long-term course can be influenced by organ damage from their initial presentation, disease relapses, and medication toxicity. Recent investigations have focused on understanding disease pathophysiology and the exploration of novel therapeutic approaches. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932919     DOI: 10.1016/j.jaci.2009.07.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

Review 1.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

2.  The "multifaceted" onset of vasculitis neuropathy.

Authors:  Lorenzo Emmi; Danilo Squatrito; Giacomo Emmi; Enrico Beccastrini; Elena Silvestri
Journal:  Intern Emerg Med       Date:  2012-12-20       Impact factor: 3.397

3.  Fever of unknown origin: large vessel vasculitis diagnosed by PET/CT.

Authors:  Dubravka Bosnić; Marko Barešić; Ivan Padjen; Antonija Balenović; Kamelija Zarković; Branimir Anić
Journal:  Rheumatol Int       Date:  2012-03-28       Impact factor: 2.631

4.  Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis.

Authors:  Olga Vera-Lastra; Jesús Sepúlveda-Delgado; María del Pilar Cruz-Domínguez; Gabriela Medina; Moisés Casarrubias-Ramírez; Luis E Molina-Carrión; Luis F Pineda-Galindo; Arturo Olvera-Acevedo; Claudia Hernández-Gonzalez; Luis J Jara
Journal:  Clin Rheumatol       Date:  2014-11-27       Impact factor: 2.980

Review 5.  Peripheral neuropathies in rheumatic disease--a guide to diagnosis.

Authors:  Jean-Michel Vallat; Magalie Rabin; Laurent Magy
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

6.  Red blood cell distribution width as a useful indicator to predict systemic vasculitis in patients with cutaneous vasculitis.

Authors:  Dae Suk Kim; Dongyun Shin; Tae-Gyun Kim; Sung Hee Kim; Do Young Kim; Soo Min Kim; Min-Geol Lee
Journal:  Rheumatol Int       Date:  2014-10-05       Impact factor: 2.631

7.  Assessment of the association between red blood cell distribution width and disease activity in patients with systemic vasculitis.

Authors:  Jing Hong; Bin Zhu; Xintian Cai; Shanshan Liu; Shasha Liu; Qing Zhu; Xiayire Aierken; Ayiguzaili Aihemaiti; Ting Wu; Nanfang Li
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

8.  Paraneoplastic leukocytoclastic vasculitis as an initial presentation of malignant pleural mesothelioma: a case report.

Authors:  Shu Fen Wong; Lisa Newland; Thomas John; Shane C White
Journal:  J Med Case Rep       Date:  2012-08-31

9.  A Rare Case of SARS-CoV-2-Induced Microscopic Polyangiitis.

Authors:  Nishant Allena; Jay Patel; Georgette Nader; Madanmohan Patel; Boris Medvedovsky
Journal:  Cureus       Date:  2021-05-26

Review 10.  CMR in inflammatory vasculitis.

Authors:  Subha V Raman; Ashish Aneja; Wael N Jarjour
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-30       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.